Go to page
 

Bibliographic Metadata

Title
Proteolysis in Helicobacter pylori-induced gastric cancer
AuthorPosselt, Gernot ; Crabtree, Jean E. ; Wessler, Silja
Published in
Toxins, Basel, 2017, Vol. 9, Issue 4, page 1-18
PublishedMDPI, 2017
LanguageEnglish
Document typeJournal Article
Keywords (EN)Helicobacter pylori / protease / MMP / ADAM / TIMP / E-cadherin / HtrA / EGFR
ISSN2072-6651
URNurn:nbn:at:at-ubs:3-5683 Persistent Identifier (URN)
DOI10.3390/toxins9040134 
Restriction-Information
 The work is publicly available
Files
Proteolysis in Helicobacter pylori-induced gastric cancer [1.47 mb]
Links
Reference
Classification
Abstract (English)

Persistent infections with the human pathogen and class-I carcinogen Helicobacter pylori (H. pylori) are closely associated with the development of acute and chronic gastritis, ulceration, gastric adenocarcinoma and lymphoma of the mucosa-associated lymphoid tissue (MALT) system. Disruption and depolarization of the epithelium is a hallmark of H. pylori-associated disorders and requires extensive modulation of epithelial cell surface structures. Hence, the complex network of controlled proteolysis which facilitates tissue homeostasis in healthy individuals is deregulated and crucially contributes to the induction and progression of gastric cancer through processing of extracellular matrix (ECM) proteins, cell surface receptors, membrane-bound cytokines, and lateral adhesion molecules. Here, we summarize the recent reports on mechanisms how H. pylori utilizes a variety of extracellular proteases, involving the proteases Hp0169 and high temperature requirement A (HtrA) of bacterial origin, and host matrix-metalloproteinases (MMPs), a disintegrin and metalloproteinases (ADAMs) and tissue inhibitors of metalloproteinases (TIMPs). H. pylori-regulated proteases represent predictive biomarkers and attractive targets for therapeutic interventions in gastric cancer.

License
CC-BY-License (4.0)Creative Commons Attribution 4.0 International License